NATALLIA KLESHCHANKA: Open Payments
NPI 1942780390 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 15 payments from 9 companies in 2025. Trend: 2023 $344 · 2024 $726 · 2025 $475
Food & beverage: $395Education: $80
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $148 |
| Astellas Pharma US Inc | 3 | $123 |
| Lilly USA, LLC | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Insulet Corporation | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $13 |
Products named: JARDIANCE, MOUNJARO, Veozah, UZEDY, Omnipod, PURIFIED CORTROPHIN GEL, GVOKE HYPOPEN, XYOSTED.
Industry payments across NY — which companies pay providers there.
